EichorEICHOR
Study identifier: NCT06120140 Synced from ClinicalTrials.gov · August 02, 2026
● Active Not Recruiting

Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib

Condition: Carcinoma, Non-Small-Cell Lung  ·  Sponsor: Janssen Research & Development, LLC

PhasePhase 2
Planned participants305
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of this study is to evaluate whether enhanced dermatologic management can reduce incidence of grade greater than or equal to (\>=) 2 dermatologic adverse events of interest (DAEIs) when compared with standard-of-care skin management and with modified enhanced dermatologic management in participants with locally advanced or metastatic stage IIIB/C-IV epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC) treated first-line with amivantamab and lazertinib. The study also includes Expansion cohorts (in 2 different schedules) to evaluate enhanced dermatologic management and early intervention for DAEIs or paronychia, in participants receiving subcutaneous amivantamab and lazertinib. A substudy will enroll participants from Arms A and B who experience specific new-onset or persistent DAEIs (Grade \>=2) during treatment with intravenous (IV) amivantamab and lazertinib. This substudy aims to assess the reactive use of dermatologic treatment strategies in these participants.

This description comes directly from the study's public registry record.

Talk to the study team

No contact information is available for this study as per the public registry record.

Always discuss trial participation with your own doctor first.

Locations (93)

Ironwood Cancer and Research CenterChandler, Arizona, United States
City of HopeDuarte, California, United States
Providence FullertonFullerton, California, United States
Los Angeles Cancer NetworkGlendale, California, United States
City of Hope SeacliffHuntington Beach, California, United States
City of Hope Orange County Lennar Foundation Cancer CenterIrvine, California, United States
City of Hope Long Beach ElmLong Beach, California, United States
Cancer and Blood Specialty ClinicLos Alamitos, California, United States
Keck Hospital of USCLos Angeles, California, United States
USC Norris Oncology Hematology Newport BeachNewport Beach, California, United States
Kaiser Permanente Oakland Medical CenterOakland, California, United States
Kaiser Permanente Roseville Medical CenterRoseville, California, United States

+ 81 more locations — full list on the registry record.

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →